Generic products are cost effective and speedy surrogates for high-priced innovator/branded products. The prerequisite for the development of a generic product is therapeutic equivalence (comprising pharmaceutical equivalence and bioequivalence) to the innovator product, thus ensuring comparable efficacy and safety profile. 

The probability of successfully developing a bioequivalent product can be improved by developing a formulation equivalent to the reference listed drug (RLD), in terms of the quantitative, solid-state characteristics of the active pharmaceutical ingredient (API) and the manufacturing process. This can be achieved by a systematic and thorough characterisation of the RLD. The present study was aimed at developing a methodology for characterisation of ranitidine hydrochloride tablets, with special emphasis on the solid-state characterisation of the API in the tablet.

A differential solubility method was employed for the separation and quantification of excipients present in the tablet. Solid-state properties were characterised using a range of microscopic, thermal, spectroscopic and crystallographic techniques. In addition, results were confirmed by preparing inhouse tablets of the polymorphic forms I and II, using the decoded quantitative formula.

NOTE: does not own this book neither created nor scanned. We just providing the link already available on internet. If any way it violates the law or has any issues then kindly mail us: or Contact Us for this(Link Removal).

Download Your Book

Post a Comment


Anonymous said…
Hey your companian website once uploaded Problem plus in IIT by Adas gupta
tell me when will you upload this